|
|
|||||||
 |
|
|
LinkBack | Thread Tools | Display Modes |
03-29-2010, 03:56 PM
|
|||
|
|||
NexMed Files Investigational New Drug Application with FDA for Cancer Drug Candidate
SAN DIEGO----NexMed, Inc. , a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the Company has filed an Investigational New Drug application with the U.S.
    
|
|
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| MabCure files provisional patent application for ovarian cancer diagnostic antibodies | cancerfr | Ovarian Cancer | 0 | 08-04-2010 05:23 PM |
| ImmunoCellular Files Orphan Drug Application For ICT-107 | cancerfr | Extracranial Germ Cell Tumor | 0 | 05-06-2010 02:48 PM |
| NexMed Files Investigational New Drug Application With FDA For Cancer Drug Candidate | cancerfr | Adrenocortical Carcinoma | 0 | 04-01-2010 06:41 AM |
| NexMed files IND with FDA for Phase II trial of PrevOnco for HCC (News-Medical-Net) | cancerfr | Adrenocortical Carcinoma | 0 | 03-29-2010 10:29 PM |
| NexMed Files Investigational New Drug Application with FDA for Cancer Drug Candidate | cancerfr | Adrenocortical Carcinoma | 0 | 03-29-2010 03:56 PM |
Linear Mode
